TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Biopharmaceutical Contract Manufacturing (BCMO) Market Research Report 2022

Global Biopharmaceutical Contract Manufacturing (BCMO) Market Research Report 2022

  • Category:Life Sciences
  • Published on : 25 November 2022
  • Pages :84
  • Formats:
  • Report Code:SMR-7494868
OfferClick for best price

Best Price: $2320

Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing BCMO Market

The global Biopharmaceutical Contract Manufacturing BCMO market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Contract Manufacturing BCMO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Contract Manufacturing BCMO market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Contract Manufacturing BCMO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Contract Manufacturing BCMO market.

Global Biopharmaceutical Contract Manufacturing BCMO Scope and Market Size

Biopharmaceutical Contract Manufacturing (BCMO) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing (BCMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Mammalian Based Manufacturing
Microbial Based Manufacturing
Other
Segment by Application
Bio-Pharmaceutical Companies
Pharmaceutical Companies
Drug Discovery Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Lonza Group Ltd
Boehringher Ingelheim
Sandoz
Fujifilm Diosynth Biotechnology
Rentschler Biotechnologie
Celonic GmbH
BIOMEVA GmbH
ProBioGen AG

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biopharmaceutical Contract Manufacturing BCMO product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biopharmaceutical Contract Manufacturing BCMO, with price, sales, revenue, and global market share of Biopharmaceutical Contract Manufacturing BCMO from 2019 to 2022.

Chapter 3, the Biopharmaceutical Contract Manufacturing BCMO competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biopharmaceutical Contract Manufacturing BCMO breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biopharmaceutical Contract Manufacturing BCMO market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceutical Contract Manufacturing BCMO.

Chapter 13, 14, and 15, to describe Biopharmaceutical Contract Manufacturing BCMO sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biopharmaceutical Contract Manufacturing BCMO Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Mammalian Based Manufacturing
1.2.3 Microbial Based Manufacturing
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Bio-Pharmaceutical Companies
1.3.3 Pharmaceutical Companies
1.3.4 Drug Discovery Companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Perspective (2017-2028)
2.2 Biopharmaceutical Contract Manufacturing (BCMO) Growth Trends by Region
2.2.1 Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical Contract Manufacturing (BCMO) Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical Contract Manufacturing (BCMO) Market Dynamics
2.3.1 Biopharmaceutical Contract Manufacturing (BCMO) Industry Trends
2.3.2 Biopharmaceutical Contract Manufacturing (BCMO) Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing (BCMO) Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing (BCMO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing (BCMO) Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing (BCMO) Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing (BCMO) Revenue
3.4 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing (BCMO) Revenue in 2021
3.5 Biopharmaceutical Contract Manufacturing (BCMO) Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing (BCMO) Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing (BCMO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing (BCMO) Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Contract Manufacturing (BCMO) Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
6.2 North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
6.3 North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
7.2 Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
7.3 Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
9.2 Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
9.3 Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Lonza Group Ltd
11.1.1 Lonza Group Ltd Company Detail
11.1.2 Lonza Group Ltd Business Overview
11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.1.4 Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.1.5 Lonza Group Ltd Recent Development
11.2 Boehringher Ingelheim
11.2.1 Boehringher Ingelheim Company Detail
11.2.2 Boehringher Ingelheim Business Overview
11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.2.4 Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.2.5 Boehringher Ingelheim Recent Development
11.3 Sandoz
11.3.1 Sandoz Company Detail
11.3.2 Sandoz Business Overview
11.3.3 Sandoz Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.3.4 Sandoz Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.3.5 Sandoz Recent Development
11.4 Fujifilm Diosynth Biotechnology
11.4.1 Fujifilm Diosynth Biotechnology Company Detail
11.4.2 Fujifilm Diosynth Biotechnology Business Overview
11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.4.4 Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.4.5 Fujifilm Diosynth Biotechnology Recent Development
11.5 Rentschler Biotechnologie
11.5.1 Rentschler Biotechnologie Company Detail
11.5.2 Rentschler Biotechnologie Business Overview
11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.5.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.5.5 Rentschler Biotechnologie Recent Development
11.6 Celonic GmbH
11.6.1 Celonic GmbH Company Detail
11.6.2 Celonic GmbH Business Overview
11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.6.4 Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.6.5 Celonic GmbH Recent Development
11.7 BIOMEVA GmbH
11.7.1 BIOMEVA GmbH Company Detail
11.7.2 BIOMEVA GmbH Business Overview
11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.7.4 BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.7.5 BIOMEVA GmbH Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Detail
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.8.5 ProBioGen AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Mammalian Based Manufacturing
Table 3. Key Players of Microbial Based Manufacturing
Table 4. Key Players of Other
Table 5. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Region (2017-2022)
Table 9. Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Region (2023-2028)
Table 11. Biopharmaceutical Contract Manufacturing (BCMO) Market Trends
Table 12. Biopharmaceutical Contract Manufacturing (BCMO) Market Drivers
Table 13. Biopharmaceutical Contract Manufacturing (BCMO) Market Challenges
Table 14. Biopharmaceutical Contract Manufacturing (BCMO) Market Restraints
Table 15. Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Players (2017-2022)
Table 17. Global Top Biopharmaceutical Contract Manufacturing (BCMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing (BCMO) as of 2021)
Table 18. Ranking of Global Top Biopharmaceutical Contract Manufacturing (BCMO) Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing (BCMO) Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biopharmaceutical Contract Manufacturing (BCMO) Product Solution and Service
Table 22. Date of Enter into Biopharmaceutical Contract Manufacturing (BCMO) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue Market Share by Type (2017-2022)
Table 26. Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue Market Share by Type (2023-2028)
Table 28. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue Market Share by Application (2017-2022)
Table 30. Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue Market Share by Application (2023-2028)
Table 32. North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Lonza Group Ltd Company Detail
Table 43. Lonza Group Ltd Business Overview
Table 44. Lonza Group Ltd Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 45. Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 46. Lonza Group Ltd Recent Development
Table 47. Boehringher Ingelheim Company Detail
Table 48. Boehringher Ingelheim Business Overview
Table 49. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 50. Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 51. Boehringher Ingelheim Recent Development
Table 52. Sandoz Company Detail
Table 53. Sandoz Business Overview
Table 54. Sandoz Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 55. Sandoz Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 56. Sandoz Recent Development
Table 57. Fujifilm Diosynth Biotechnology Company Detail
Table 58. Fujifilm Diosynth Biotechnology Business Overview
Table 59. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 60. Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 61. Fujifilm Diosynth Biotechnology Recent Development
Table 62. Rentschler Biotechnologie Company Detail
Table 63. Rentschler Biotechnologie Business Overview
Table 64. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 65. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 66. Rentschler Biotechnologie Recent Development
Table 67. Celonic GmbH Company Detail
Table 68. Celonic GmbH Business Overview
Table 69. Celonic GmbH Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 70. Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 71. Celonic GmbH Recent Development
Table 72. BIOMEVA GmbH Company Detail
Table 73. BIOMEVA GmbH Business Overview
Table 74. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 75. BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 76. BIOMEVA GmbH Recent Development
Table 77. ProBioGen AG Company Detail
Table 78. ProBioGen AG Business Overview
Table 79. ProBioGen AG Biopharmaceutical Contract Manufacturing (BCMO) Product
Table 80. ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022) & (US$ Million)
Table 81. ProBioGen AG Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Type: 2021 VS 2028
Figure 2. Mammalian Based Manufacturing Features
Figure 3. Microbial Based Manufacturing Features
Figure 4. Other Features
Figure 5. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Application in 2021 & 2028
Figure 6. Bio-Pharmaceutical Companies Case Studies
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Drug Discovery Companies Case Studies
Figure 9. Other Case Studies
Figure 10. Biopharmaceutical Contract Manufacturing (BCMO) Report Years Considered
Figure 11. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Region: 2021 VS 2028
Figure 14. Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Players in 2021
Figure 15. Global Top Biopharmaceutical Contract Manufacturing (BCMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing (BCMO) as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing (BCMO) Revenue in 2021
Figure 17. North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Country (2017-2028)
Figure 19. United States Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Country (2017-2028)
Figure 23. Germany Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Region (2017-2028)
Figure 31. China Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Country (2017-2028)
Figure 39. Mexico Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Country (2017-2028)
Figure 43. Turkey Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Biopharmaceutical Contract Manufacturing (BCMO) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Lonza Group Ltd Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 46. Boehringher Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 47. Sandoz Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 48. Fujifilm Diosynth Biotechnology Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 49. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 50. Celonic GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 51. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 52. ProBioGen AG Revenue Growth Rate in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount